Peripheral Artery Disease and Your Heart

Clinical Trial Finder

Many patients with type 2 diabetes are interested in participating in the latest research regarding their condition. This Clinical Trial Finder can help you—or a loved one—easily find ongoing cardiovascular clinical research trials for which you might qualify. This list is a service of the U.S. National Institutes of Health called clinicaltrials.gov, a database of publicly and privately supported clinical studies.

Simply click on the trial below that interests you to learn how you might participate.

Effect of High Carbohydrate vs. Low Carbohydrate Diet in Type 2 Diabetes

Conditions:   Diabetes Mellitus;   Diabetes Mellitus, Type 2
Interventions:   Other: High Carbohydrate (glycogen loading);   Other: Low carbohydrate (No Glycogen Loading)
Sponsor:   University of Virginia
Not yet recruiting

Effect of Group Patient Education on Glycemic Control Among People Living With Type 2 Diabetes in Vietnam

Condition:   Type 2 Diabetes
Interventions:   Other: patient education and self-management intervention in a low-resource setting on diabetes knowledge and levels of blood glucose control;   Other: Usual diabetes care alone
Sponsor:   Hanoi Medical University
Completed

SWIFT: Study of Women, Infant Feeding and Type 2 Diabetes After GDM Pregnancy

Condition:   Type 2 Diabetes
Intervention:  
Sponsors:   Kaiser Permanente;   Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD);   National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK);   American Diabetes Association;   W.K. Kellogg Foundation;   Centers for Disease Control and Prevention;   National Heart, Lung, and Blood Institute (NHLBI);   University of Toronto
Active, not recruiting

Normoalbuminuric Chronic Kidney Disease in Type 2 Diabetes

Condition:   Chronic Kidney Diseases
Intervention:   Diagnostic Test: Albumin creatinine ratio
Sponsor:   Assiut University
Not yet recruiting

Effect of Cinnamomum Zeylanicum on Glycemic Levels of Adult Patients With Type 2 Diabetes

Condition:   Type 2 Diabetes
Interventions:   Dietary Supplement: Cinnamomum zeylanicum;   Other: Placebo
Sponsor:   Universidad de Sonora
Completed

Effect of MEDiterranean Diet on the microBIOME of Individuals With Type 2 Diabetes

Condition:   Type 2 Diabetes
Intervention:   Other: Individualized structured dietary plan based on MD
Sponsor:   Universidade Nova de Lisboa
Recruiting

Steno2tech - Continuous Glucose Monitoring and Type 2 Diabetes.

Condition:   Type 2 Diabetes Treated With Insulin
Interventions:   Device: CGM;   Behavioral: training course;   Behavioral: Peer-support
Sponsor:   Steno Diabetes Center Copenhagen
Not yet recruiting

Metabolic, Physical Responses To Exercise In Patients With Type 2 Diabetes Mellitus

Conditions:   Type2 Diabetes Mellitus;   Exercise
Intervention:   Other: exercise
Sponsor:   Pamukkale University
Recruiting

Effect of Renin-angiotensin-system Blockade on Urinary Free Light Chains in Patients With Type 2 Diabetes Mellitus

Conditions:   Type 2 Diabetes;   Hypertension
Intervention:   Drug: amlodipine, hydralazine, terazosin or hydrochlorothiazide
Sponsor:   Tulane University School of Medicine
Completed

Evaluating the Effects of a Study Medication on Exercise Function in Type 2 Diabetes

Condition:   Type 2 Diabetes
Interventions:   Drug: Acipimox;   Drug: Placebo
Sponsors:   University of Colorado, Denver;   US Department of Veterans Affairs;   Pfizer
Active, not recruiting

Safety and Efficacy Study of Exenatide Once Weekly in Adolescents With Type 2 Diabetes

Condition:   Children and Adolescent With Type 2 Diabetes
Interventions:   Drug: Exenatide Once Weekly;   Drug: Placebo
Sponsor:   AstraZeneca
Active, not recruiting

A Research Study, Looking at How NovoMix® Works in People With Type 2 Diabetes in Local Clinical Practice in Algeria

Condition:   Diabetes Mellitus, Type 2
Intervention:   Drug: BIAsp 30
Sponsor:   Novo Nordisk A/S
Withdrawn

Fibre Grain Herb Trial in Type 2 Diabetes

Condition:   Type 2 Diabetes
Interventions:   Dietary Supplement: Dietary, Herbal;   Dietary Supplement: Positive Control
Sponsors:   St. Michael's Hospital, Toronto;   Canadian Diabetes Association
Completed

Study of Exenatide Once-Weekly Suspension in Chinese Patients With Type 2 Diabetes Mellitus

Condition:   Type 2 Diabetes
Intervention:   Drug: Exenatide Once-Weekly Suspension
Sponsor:   AstraZeneca
Withdrawn

A Study of Tirzepatide (LY3298176) in Participants With Type 2 Diabetes on Metformin With or Without Sulfonylurea (SURPASS-AP-Combo)

Condition:   Type 2 Diabetes
Interventions:   Drug: Tirzepatide;   Drug: Insulin Glargine
Sponsor:   Eli Lilly and Company
Recruiting

A Study of Tirzepatide (LY3298176) Compared With Dulaglutide on Major Cardiovascular Events in Participants With Type 2 Diabetes

Condition:   Type 2 Diabetes Mellitus
Interventions:   Drug: Tirzepatide;   Drug: Dulaglutide
Sponsor:   Eli Lilly and Company
Not yet recruiting

A Study of Tirzepatide (LY3298176) Versus Semaglutide Once Weekly as Add-on Therapy to Metformin in Participants With Type 2 Diabetes

Condition:   Type 2 Diabetes
Interventions:   Drug: Tirzepatide;   Drug: Semaglutide
Sponsor:   Eli Lilly and Company
Active, not recruiting

A Study of Tirzepatide (LY3298176) Versus Placebo in Participants With Type 2 Diabetes Inadequately Controlled on Insulin Glargine With or Without Metformin

Condition:   Type 2 Diabetes
Interventions:   Drug: Tirzepatide;   Drug: Placebo
Sponsor:   Eli Lilly and Company
Active, not recruiting

How Does the Spirituality of Patients With Type 2 Diabetes Influence Their Self-management?

Condition:   Type 2 Diabetes
Intervention:  
Sponsors:   Natasha Duke;   University of Southampton
Completed

Colesevelam for Children With Type 2 Diabetes

Condition:   Type 2 Diabetes Mellitus
Interventions:   Drug: High-dose colesevelam;   Drug: Low-dose colesevelam
Sponsor:   Daiichi Sankyo, Inc.
Active, not recruiting

A Research Study, Looking at How Tresiba® Works in People With Type 2 Diabetes in Local Clinical Practice in Russia

Condition:   Diabetes Mellitus, Type 2
Intervention:   Drug: insulin degludec
Sponsor:   Novo Nordisk A/S
Enrolling by invitation

A Study to Investigate the Effect of MEDI0382 on Hepatic Glycogen Metabolism in Overweight and Obese Subjects With Type 2 Diabetes Mellitus.

Condition:   Type 2 Diabetes Mellitus
Interventions:   Drug: MEDI0382;   Drug: Placebo;   Drug: Liraglutide
Sponsor:   MedImmune LLC
Active, not recruiting

Safety Study of Mesenchymal Precursor Cells in Type 2 Diabetes

Condition:   Type 2 Diabetes
Intervention:   Drug: Mesenchymal Precursor Cells (MPCs)
Sponsor:   Mesoblast, Ltd.
Completed

Reducing Emergency Department Visits and Improving Glucose Control in Uncontrolled Type 2 Diabetes Using CGM Sensors at Hospital Discharge

Condition:   Type 2 Diabetes Mellitus
Interventions:   Device: Continuous Glucose Monitoring Sensor;   Other: Diabetes Management Instructions
Sponsor:   Albert Einstein Healthcare Network
Recruiting

Time in Range (TIR) and Time Below Range (TBR) in Insulin-Treated Elderly Patients With Type 2 Diabetes

Condition:   Continuous Glucose Monitoring
Interventions:   Device: Application of the FreeStyle Libre Flash Glucose CGM.;   Diagnostic Test: InBody 270 multifrequency bioimpedance
Sponsors:   Cline Research Center;   Abbott Diabetes Care
Not yet recruiting

Efficacy and Safety of Sotagliflozin Versus Placebo in Patients With Type 2 Diabetes Mellitus on Background of Metformin

Condition:   Type 2 Diabetes Mellitus
Interventions:   Drug: Sotagliflozin (SAR439954);   Drug: Placebo;   Drug: Metformin
Sponsors:   Lexicon Pharmaceuticals;   Sanofi
Completed

Remission Evaluation of Metabolic Interventions in Type 2 Diabetes (REMIT Pilot Trial)

Condition:   Type 2 Diabetes Mellitus
Interventions:   Drug: insulin glargine;   Drug: metformin;   Drug: acarbose;   Behavioral: lifestyle therapy;   Other: Standard glycemic care
Sponsors:   Population Health Research Institute;   Hamilton Health Sciences Corporation
Completed

Efficacy and Bone Safety of Sotagliflozin Dose 1 and Dose 2 Versus Placebo in Subjects With Type 2 Diabetes Mellitus Who Have Inadequate Glycemic Control

Condition:   Type 2 Diabetes Mellitus
Interventions:   Drug: Sotagliflozin (SAR439954);   Drug: Placebo
Sponsors:   Lexicon Pharmaceuticals;   Sanofi
Active, not recruiting

Efficacy and Safety of Sotagliflozin Versus Placebo in Subjects With Type 2 Diabetes Mellitus Who Have Inadequate Glycemic Control While Taking Insulin Alone or With Other Oral Antidiabetic Agents

Condition:   Type 2 Diabetes Mellitus
Interventions:   Drug: sotagliflozin (SAR439954);   Drug: insulin glargine (HOE901);   Drug: Placebo
Sponsors:   Lexicon Pharmaceuticals;   Sanofi
Completed

Efficacy and Safety of Sotagliflozin Versus Glimepiride and Placebo in Subjects With Type 2 Diabetes Mellitus That Are Taking Metformin Monotherapy

Condition:   Type 2 Diabetes Mellitus
Interventions:   Drug: sotagliflozin (SAR439954);   Drug: glimepiride;   Drug: metformin;   Drug: placebo
Sponsors:   Lexicon Pharmaceuticals;   Sanofi
Completed

Efficacy and Safety of Sotagliflozin Versus Placebo in Patients With Type 2 Diabetes Mellitus Not Currently Treated With Antidiabetic Therapy

Condition:   Type 2 Diabetes Mellitus
Interventions:   Drug: Sotagliflozin (SAR439954);   Drug: Placebo
Sponsors:   Lexicon Pharmaceuticals;   Sanofi
Completed

Efficacy and Safety of Sotagliflozin Versus Placebo in Patients With Type 2 Diabetes Mellitus on Background of Sulfonylurea Alone or With Metformin

Condition:   Type 2 Diabetes Mellitus
Interventions:   Drug: Sotagliflozin (SAR439954);   Drug: placebo;   Drug: Metformin;   Drug: Sulfonylurea
Sponsors:   Lexicon Pharmaceuticals;   Sanofi
Completed

Efficacy and Safety of Sotagliflozin Versus Placebo and Empagliflozin in Subjects With Type 2 Diabetes Mellitus Who Have Inadequate Glycemic Control While Taking a DPP4 Inhibitor Alone or With Metformin

Condition:   Type 2 Diabetes Mellitus
Interventions:   Drug: Sotagliflozin (SAR439954);   Drug: Empagliflozin;   Drug: Placebo
Sponsors:   Lexicon Pharmaceuticals;   Sanofi
Completed

Prevalence and Determinants of Subclinical Cardiovascular Dysfunction in Adults With Type 2 Diabetes Mellitus

Conditions:   Diabetes Mellitus, Type 2;   Diabetic Cardiomyopathies
Interventions:   Diagnostic Test: Cardiovascular magnetic resonance (CMR) imaging and magnetic resonance spectroscopy;   Diagnostic Test: Transthoracic echocardiography;   Diagnostic Test: Computed tomography coronary artery calcium scoring;   Diagnostic Test: Cardiopulmonary exercise testing
Sponsor:   University of Leicester
Recruiting

Study to Evaluate Safety and Efficacy of Dapagliflozin and Saxagliptin in Patients With Type 2 Diabetes Mellitus Aged 10 to Below 18 Years Old

Condition:   Diabetes Mellitus, Type 2
Interventions:   Drug: Dapagliflozin;   Drug: Saxagliptin;   Drug: Placebo
Sponsor:   AstraZeneca
Recruiting

ABO-GLYC in Type 2 Diabetes

Condition:   Type2 Diabetes
Interventions:   Device: ABO-GLYC;   Other: ABO-GLYC Placebo
Sponsors:   Aboca Spa Societa' Agricola;   Latis S.r.l.;   Fondazione Edmund Mach
Recruiting

A Study in CKD Patients With Type 2 Diabetes Mellitus and Albuminuria

Conditions:   Chronic Kidney Disease;   Type 2 Diabetes Mellitus
Interventions:   Drug: AZD1722;   Drug: Placebo
Sponsors:   Ardelyx;   AstraZeneca
Completed

A Long-term Study on the Side Effects of TRADIANCE in Japanese Patients With Type 2 Diabetes

Condition:   Diabetes Mellitus, Type 2
Interventions:   Drug: TRADIANCE® Combination Tablets AP;   Drug: TRADIANCE® Combination Tablets BP
Sponsors:   Boehringer Ingelheim;   Eli Lilly and Company
Active, not recruiting

Multiple Escalating Oral Doses Study of PF-07081532 in Adult Participants With Type 2 Diabetes Mellitus

Condition:   Diabetes Mellitus Type 2
Interventions:   Drug: PF-07081532;   Other: Placebo;   Drug: Clopidogrel
Sponsor:   Pfizer
Recruiting

Safety and Efficacy Study of Sotagliflozin on Glucose Control in Patients With Type 2 Diabetes, Moderate Impairment of Kidney Function, and Inadequate Blood Sugar Control

Conditions:   Type2 Diabetes Mellitus;   Chronic Kidney Disease Stage 3
Interventions:   Drug: Placebo;   Drug: Sotagliflozin (SAR439954)
Sponsors:   Lexicon Pharmaceuticals;   Sanofi
Completed

Biweekly Interval Intermittent Fasting for Type 2 Diabetes, a Safety Study

Conditions:   Diabetes Type 2;   Pre-diabetes
Intervention:   Other: Intermittent Fasting
Sponsor:   gino gaddini
Recruiting

A Study to Evaluate Safety and Effects of Sotagliflozin Dose 1 and Dose 2 on Glucose Control in Patients With Type 2 Diabetes, Severe Impairment of Kidney Function and Inadequate Blood Sugar Control

Conditions:   Type 2 Diabetes Mellitus;   Chronic Kidney Disease Stage 4
Interventions:   Drug: Placebo;   Drug: Sotagliflozin (SAR439954)
Sponsors:   Lexicon Pharmaceuticals;   Sanofi
Completed

Neuromuscular Adaptations to Exercise In Patients With Type 2 Diabetes Mellitus

Conditions:   Gait, Unsteady;   Aerobic Exercise
Intervention:   Other: Aerobic Exercise
Sponsor:   Pamukkale University
Completed

Effect of Meal Timing in T2D on Hepatocytes SRIT1 and Clock Genes

Conditions:   Type 2 Diabetes;   Obesity
Interventions:   Other: Breakfast Diet;   Other: Allday Diet
Sponsor:   Tel Aviv University
Not yet recruiting

Placebo-Controlled Clinical Nutrition Study of the Metabolic Effects of Food Product WBF-0011 in Type 2 Diabetes

Condition:   Type 2 Diabetes Mellitus
Interventions:   Other: Medical Food Formulation 1;   Other: Medical Food Formulation 2;   Other: Placebo
Sponsor:   Pendulum Therapeutics
Enrolling by invitation

Effect of VeSTAL Device in Type 2 Diabetes Mellitus

Conditions:   Type 2 Diabetes;   Metabolic Syndrome
Interventions:   Device: Vestal Device;   Device: Placebo device
Sponsors:   Neurovalens Ltd.;   Compliance Solutions Ltd;   University College Dublin;   Exploristics Ltd
Enrolling by invitation

Safety, Pharmacokinetics and Efficacy of Bimagrumab in Overweight and Obese Patients With Type 2 Diabetes

Condition:   Diabetes Mellitus, Type 2
Interventions:   Drug: BYM338 10 mg/kg;   Other: Placebo
Sponsor:   Novartis Pharmaceuticals
Completed

Inhibition of Urinary Angiotensinogen and the Reduction of Blood Pressure by SGLT2 Inhibition in Patients With Type 2 Diabetes

Conditions:   Type 2 Diabetes;   Hypertension
Interventions:   Drug: Dapagliflozin;   Drug: Sulfonylurea;   Drug: Placebo
Sponsors:   Tulane University School of Medicine;   AstraZeneca
Completed

Effect of Short-Term Beta-Cell Rest in Adolescents and Young Adults With Type 2 Diabetes Mellitus

Conditions:   Obesity;   Overweight;   Diabetes Mellitus, Type 2
Intervention:  
Sponsor:   National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Completed

A Study Using Medical Records of Danish People With Type 2 Diabetes Comparing Empagliflozin and Liraglutide in the Occurrence of Serious Cardiovascular Disease

Condition:   Diabetes Mellitus, Type 2
Interventions:   Drug: Empagliflozin;   Drug: Liraglutide
Sponsor:   Boehringer Ingelheim
Active, not recruiting

Evaluation of 2 Diets With Different Starch Digestibility Profiles on Daily Glycemic Profile, in T2D Patients

Condition:   Type2 Diabetes
Interventions:   Other: Balanced diet high in Slowly Digestible Starch;   Other: Balanced diet low in Slowly Digestible Starch
Sponsors:   Mondelēz International, Inc.;   Centre de Recherche en Nutrition Humaine Rhone-Alpe;   Biofortis Mérieux NutriSciences
Completed

Tenelia Elderly CGMS Study(TEDDY)

Condition:   Type 2 Diabetes Mellitus
Interventions:   Drug: Teneligliptin;   Drug: Placebo
Sponsor:   Handok Inc.
Active, not recruiting

Orange Juice and Glycaemic Control in Type 2 Diabetes Mellitus

Condition:   Diabetes Mellitus, Type 2
Interventions:   Other: orange juice concentrate;   Other: Sugar-sweetened orange-flavoured beverage;   Other: Whole orange juice with skin removed
Sponsors:   Hasselt University;   Hochschule Geisenheim University
Recruiting

Continuous Glucose Monitoring & Management In Type 2 Diabetes (T2D)

Condition:   Diabetes Mellitus, Type 2
Interventions:   Device: CGM;   Device: SMBG
Sponsor:   DexCom, Inc.
Active, not recruiting

A Research Study to See How Semaglutide Works Compared to Placebo in People With Type 2 Diabetes and Chronic Kidney Disease

Condition:   Diabetes Mellitus, Type 2
Interventions:   Drug: Semaglutide;   Drug: Placebo (semaglutide)
Sponsor:   Novo Nordisk A/S
Recruiting

Diabetes-Specific Formula in Individuals With Type 2 Diabetes

Condition:   Diabetes Mellitus, Type 2
Interventions:   Other: Diabetes-Specific Formula;   Other: Bread with Spread;   Other: Mashed Potato
Sponsor:   Abbott Nutrition
Not yet recruiting

A Study to Observe the Effectiveness of Empagliflozin, Other SGLT-2 Inhibitors, or DPP-4 Inhibitors in Patients With Type 2 Diabetes

Condition:   Diabetes Mellitus, Type 2
Interventions:   Drug: Subjects treated with Empagliflozin or any Sodium-glucose cotransporter-2 (SGLT-2) inhibitor;   Drug: Subjects treated with Dipeptidyl peptidase-4 (DPP-4) inhibitor
Sponsor:   Boehringer Ingelheim
Active, not recruiting

Single and Multiple Ascending Doses of MEDI6570 in Subjects With Type 2 Diabetes Mellitus

Conditions:   Atherosclerosis;   Cardiovascular Disease
Interventions:   Biological: MEDI6570;   Biological: Placebo;   Biological: Part B Placebo
Sponsor:   MedImmune LLC
Active, not recruiting

A Heart Disease Study of Semaglutide in Patients With Type 2 Diabetes

Condition:   Diabetes Mellitus, Type 2
Interventions:   Drug: Semaglutide;   Drug: Placebo (semaglutide)
Sponsor:   Novo Nordisk A/S
Recruiting

A Study of Tirzepatide in Chinese Participants With Type 2 Diabetes Mellitus

Condition:   Diabetes Mellitus, Type 2
Interventions:   Drug: Tirzepatide;   Drug: Placebo
Sponsor:   Eli Lilly and Company
Not yet recruiting

A Study of LY3209590 in Japanese Participants With Type 2 Diabetes Mellitus

Condition:   Diabetes Mellitus, Type 2
Interventions:   Drug: LY3209590;   Drug: Insulin Degludec
Sponsor:   Eli Lilly and Company
Recruiting

Efficacy and Safety of Oral Semaglutide Versus Empagliflozin in Subjects With Type 2 Diabetes Mellitus

Conditions:   Diabetes;   Diabetes Mellitus, Type 2
Interventions:   Drug: semaglutide;   Drug: empagliflozin
Sponsor:   Novo Nordisk A/S
Completed

Tai Chi Chuan as Rehabilitation Program for Mild Cognitive Impairment in Type 2 Diabetes Mellitus Patients

Conditions:   Diabetes Mellitus, Type 2;   Cognitive Dysfunction
Interventions:   Behavioral: Tai Chi Chuan;   Behavioral: Fitness Walking;   Behavioral: Standard Diabetic Care Education
Sponsors:   Jing Tao;   Second Affiliated Hospital of Heilongjiang University of Chinese Medicine;   Bao'an District People's Hospital of Shenzhen;   Xiyuan Hospital of China Academy of Chinese Medical Sciences;   Peking University;   University of Electronic Science and Technology of China
Not yet recruiting

A Study to Test Whether Different Doses of BI 456906 Are Effective in Treating Adults With Type 2 Diabetes.

Condition:   Diabetes Mellitus, Type 2
Interventions:   Drug: BI 456906;   Drug: Placebo;   Drug: Semaglutide
Sponsor:   Boehringer Ingelheim
Recruiting

A Research Study to Look at How Semaglutide Compared to Placebo Affects Diabetic Eye Disease in People With Type 2 Diabetes

Condition:   Diabetes Mellitus, Type 2
Interventions:   Drug: Semaglutide;   Drug: Placebo (semaglutide)
Sponsor:   Novo Nordisk A/S
Recruiting

Nephropathy In Type 2 Diabetes and Cardio-renal Events

Condition:   Diabetic Nephropathy
Interventions:   Drug: SoC therapy;   Drug: irbesartan;   Drug: ramipril;   Drug: hydrochlorothiazide;   Drug: furosemide;   Drug: amlodipine;   Drug: atenolol;   Drug: doxazosin;   Drug: clonidine;   Drug: insulin;   Drug: simvastatin;   Drug: fibrate;   Drug: erythropoietin;   Drug: aspirin
Sponsor:   University of Campania "Luigi Vanvitelli"
Completed

A Research Study Comparing a New Medicine Oral Semaglutide to Sitagliptin in People With Type 2 Diabetes

Condition:   Diabetes Mellitus, Type 2
Interventions:   Drug: Oral semaglutide;   Drug: Sitagliptin;   Drug: Placebo (oral semaglutide);   Drug: Placebo (sitagliptin)
Sponsor:   Novo Nordisk A/S
Recruiting

A Research Study Comparing a New Medicine Oral Semaglutide to Placebo in People With Type 2 Diabetes

Condition:   Diabetes Mellitus, Type 2
Interventions:   Drug: Oral semaglutide;   Drug: Placebo
Sponsor:   Novo Nordisk A/S
Recruiting

Research Study Investigating How Well Semaglutide Works in People With Type 2 Diabetes Suffering From Overweight or Obesity

Conditions:   Obesity;   Overweight
Interventions:   Drug: Semaglutide 1.0 mg;   Drug: Semaglutide 2.4 mg;   Drug: Placebo I (Semaglutide);   Drug: Placebo II (Semaglutide)
Sponsor:   Novo Nordisk A/S
Completed

Efficacy and Safety of Liraglutide in Combination With Metformin Compared to Metformin Alone, in Children and Adolescents With Type 2 Diabetes

Conditions:   Diabetes;   Diabetes Mellitus, Type 2
Interventions:   Drug: liraglutide;   Drug: placebo;   Drug: metformin
Sponsor:   Novo Nordisk A/S
Completed

A Research Study to Compare Semaglutide to Insulin Aspart, When Taken Together With Metformin and Insulin Glargine, in People With Type 2 Diabetes

Condition:   Diabetes Mellitus, Type 2
Interventions:   Drug: Semaglutide;   Drug: Insulin aspart;   Drug: Insulin glargine U100
Sponsor:   Novo Nordisk A/S
Active, not recruiting

Post-authorisation Safety Study in Patients With Type 2 Diabetes to Assess the Risk of Liver Injury, Kidney Injury, Urinary Tract and Genital Infections, and Diabetic Ketoacidosis in Patients Treated With Empagliflozin, Compared to DPP-4 Inhibitors

Condition:   Diabetes Mellitus, Type 2
Interventions:   Drug: Empagliflozin;   Drug: DPP-4 inhibitors
Sponsors:   Boehringer Ingelheim;   Eli Lilly and Company
Active, not recruiting

DIA_CENTRAL:T2D Treatment Pattern in Central Europe

Condition:   Diabetes Mellitus, Type 2
Interventions:   Drug: Empagliflozin;   Drug: Sodium Glucose Transporter 2 inhibitor;   Drug: Dipeptidyl-peptidase 4 inhibitor;   Drug: Glucagon-like peptide 1 agonist
Sponsor:   Boehringer Ingelheim
Active, not recruiting

Project MiNT: Assessing the Impact of Food & Video-Based Nutrition Education on Patients With Poorly Controlled Diabetes

Condition:   Diabetes Mellitus, Type 2
Interventions:   Other: Medically Tailored Meals;   Behavioral: Tele-Medical Nutrition Therapy (tele-MNT)
Sponsors:   Thomas Jefferson University;   Rutgers University;   West Chester University of Pennsylvania
Recruiting

INcreasing Veteran EngagemeNT to Prevent Diabetes (INVENT)

Condition:   Prediabetes
Intervention:   Behavioral: INVENT Secure Messaging Intervention
Sponsor:   VA Office of Research and Development
Active, not recruiting

Glycemic Response in Persons With Type 2 Diabetes

Condition:   Diabetes Mellitus, Type 2
Intervention:   Other: Oral Nutrition Supplement
Sponsor:   Nestlé
Enrolling by invitation

A Research Study Looking at How Semaglutide Works in People With Type 2 Diabetes in Germany, as Part of Local Clinical Practice (SURE GERMANY)

Condition:   Diabetes Mellitus, Type 2
Intervention:   Drug: semaglutide
Sponsor:   Novo Nordisk A/S
Enrolling by invitation

A Research Study Looking at How Semaglutide Works in People With Type 2 Diabetes in France, as Part of Local Clinical Practice (SURE FRANCE)

Condition:   Diabetes Mellitus, Type 2
Intervention:   Drug: semaglutide
Sponsor:   Novo Nordisk A/S
Enrolling by invitation

Fatty Acid Regulation of Platelet Function in Diabetes

Conditions:   Thrombosis;   Type 2 Diabetes Mellitus
Intervention:   Other: omega-3 and -6 fatty acids and their 12-LOX oxylipins
Sponsors:   University of Michigan;   National Heart, Lung, and Blood Institute (NHLBI)
Active, not recruiting

A Research Study Looking at How Semaglutide Works in People With Type 2 Diabetes in United Kingdom, as Part of Local Clinical Practice (SURE UK)

Condition:   Diabetes Mellitus, Type 2
Intervention:   Drug: Semaglutide
Sponsor:   Novo Nordisk A/S
Active, not recruiting

A Research Study, Looking at How Ryzodeg® (Insulin Degludec/Insulin Aspart) Works in People With Type 2 Diabetes in Local Clinical Practice

Condition:   Diabetes Mellitus, Type 2
Intervention:   Drug: Insulin Degludec/Insulin Aspart
Sponsor:   Novo Nordisk A/S
Enrolling by invitation

A Research Study Looking at How Semaglutide Works in People With Type 2 Diabetes in The Netherlands, as Part of Local Clinical Practice (SURE NETHERLANDS)

Condition:   Diabetes Mellitus, Type 2
Intervention:   Drug: semaglutide
Sponsor:   Novo Nordisk A/S
Active, not recruiting

Comparative Effectiveness of Empagliflozin in the US

Condition:   Diabetes Mellitus, Type 2
Interventions:   Drug: Empagliflozin;   Drug: DPP-4 inhibitor
Sponsors:   Boehringer Ingelheim;   Eli Lilly and Company
Active, not recruiting

Cardio-metabolic and Inflammatory Impact of Starch Digestibility in Type 2 Diabetic Patients

Condition:   Type2 Diabetes
Interventions:   Other: Balanced diet high in Slowly Digestible Starch;   Other: Balanced diet low in Slowly Digestible Starch
Sponsors:   Mondelēz International, Inc.;   Centre de Recherche en Nutrition Humaine Rhone-Alpe;   Biofortis Mérieux NutriSciences
Recruiting

A Research Study Looking at How Semaglutide Works in People With Type 2 Diabetes in Italy, as Part of Local Clinical Practice

Condition:   Diabetes Mellitus, Type 2
Intervention:   Drug: Semaglutide
Sponsor:   Novo Nordisk A/S
Enrolling by invitation

A Research Study Looking at How Semaglutide Works in People With Type 2 Diabetes in Switzerland, as Part of Local Clinical Practice (SURE SWITZERLAND)

Condition:   Diabetes Mellitus, Type 2
Intervention:   Drug: Semaglutide
Sponsor:   Novo Nordisk A/S
Completed

Tolerance & Responsiveness Improvement for Metformin (TRIM)

Condition:   Type2 Diabetes Mellitus
Interventions:   Drug: Psyllium powder;   Drug: Metformin Extended Release Oral Tablet
Sponsor:   West Side Institute for Science and Education
Recruiting

Empa PASS on Urinary Tract Malignancies

Condition:   Diabetes Mellitus, Type 2
Interventions:   Drug: empagliflozin;   Drug: DPP-4 inhibitors;   Drug: SGLT-2 inhibitors
Sponsors:   Boehringer Ingelheim;   Eli Lilly and Company
Active, not recruiting

Intestinal Metabolic Reprogramming as a Key Mechanism of Gastric Bypass in Humans

Conditions:   Obesity;   Diabetes Mellitus, Type 2;   Endocrine System Diseases;   Glucose Metabolism Disorders;   Metabolic Diseases
Intervention:  
Sponsors:   University of Pittsburgh;   Harvard University;   National Institutes of Health (NIH);   National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Enrolling by invitation

Sarcopenia and Diabetes Mellitus

Condition:   Sarcopenia
Intervention:   Radiation: WHOLE BODY DXA
Sponsors:   Dionyssiotis, Yannis, M.D.;   University of Thessaly
Completed

Investigating the Use of Quercetin on Glucose Absorption in Obesity, and Obesity With Type 2 Diabetes

Conditions:   Obesity;   Diabetes
Interventions:   Other: Quercetin;   Other: Placebo
Sponsor:   National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Recruiting

A Study of LY900014 in Participants With Type 2 Diabetes Mellitus

Condition:   Diabetes Mellitus, Type 2
Interventions:   Drug: LY900014;   Drug: Insulin Lispro
Sponsor:   Eli Lilly and Company
Completed

Post-authorization Safety Study in Type 2 Diabetic Patients in Saudi Arabia Treated With Empagliflozin to Assess the Incidence of Ketoacidosis, Severe Complications of Urinary Tract Infection, Volume Depletion, and Dehydration

Condition:   Diabetes Mellitus, Type 2
Interventions:   Drug: Empagliflozin;   Drug: Dipeptidyl-peptidase 4 (DPP-4) inhibitors
Sponsor:   Boehringer Ingelheim
Active, not recruiting

A Single Escalating Dose Study Of Ertugliflozin (PF-04971729, MK-8835) Under Fed and Fasted Conditons In Healthy Volunteers (MK-8835-036)

Condition:   Type 2 Diabetes Mellitus
Interventions:   Drug: Ertugliflozin;   Drug: Placebo to Ertugliflozin
Sponsors:   Merck Sharp & Dohme Corp.;   Pfizer
Completed

Diabetes-Specific Formula on Long Term Glycemic Control

Condition:   Diabetes Mellitus, Type 2
Interventions:   Other: Diabetes-Specific Formula;   Other: Standard Of Care
Sponsor:   Abbott Nutrition
Not yet recruiting

A Study to Measure Stomach Emptying in Overweight Non-diabetic and Diabetic Participants Using Tirzepatide

Conditions:   Overweight;   Obesity;   Diabetes Mellitus, Type 2
Interventions:   Drug: Tirzepatide;   Drug: Acetaminophen
Sponsor:   Eli Lilly and Company
Not yet recruiting

PRECISION Study: Evaluating the Accuracy of the LabPatch Continuous Glucose Monitor

Conditions:   Type1 Diabetes Mellitus;   Type 2 Diabetes Mellitus
Intervention:   Device: LabPatch Continuous Glucose Monitoring (CGM)
Sponsors:   Joslin Diabetes Center;   Cambridge Medical Technologies, LLC
Completed

Bicycle Exercise and Lifestyle Intervention in Newly Diagnosed Diabetes

Condition:   Life Style
Intervention:   Behavioral: Lifestyle Intervention
Sponsors:   University Hospital, Basel, Switzerland;   Kantonsspital Olten;   Kantonsspital Aarau;   Luzerner Kantonsspital
Recruiting

Accuracy and Treatment Experience of Two Glucose Monitoring Systems Tested in Patients With Type 1 Diabetes and Renal Impairment

Conditions:   Diabetes Mellitus Complication;   Renal Impairment
Intervention:   Device: Simultanious CGM/FGM
Sponsor:   Vastra Gotaland Region
Active, not recruiting

Alternative Lifestyle Interventions in Vulnerable Ethnic Groups

Conditions:   Gestational Diabetes;   Pre-Eclampsia;   Type2 Diabetes;   Chronic Hypertension Complicating Pregnancy;   Primary Hypertension After Pregnancy;   Obesity
Interventions:   Behavioral: Alternative Lifestyle Interventions in Vulnerable Ethnic groups;   Behavioral: Diabetes Prevention Program (DPP) online;   Behavioral: Standard of Care
Sponsors:   Vanderbilt University Medical Center;   National Heart, Lung, and Blood Institute (NHLBI)
Not yet recruiting

A Study to Establish a New Onset Hyperglycemia and Diabetes Cohort

Conditions:   Diabetes;   Type2 Diabetes;   Diabetes Mellitus
Intervention:  
Sponsors:   Fred Hutchinson Cancer Research Center;   M.D. Anderson Cancer Center;   National Cancer Institute (NCI);   National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Recruiting

A Study of Tirzepatide (LY3298176) in Participants With Obesity or Overweight

Conditions:   Overweight;   Obesity
Interventions:   Drug: Tirzepatide;   Drug: Placebo
Sponsor:   Eli Lilly and Company
Recruiting

Mapping Genes for Type 2 (Non-Insulin Dependent) Diabetes Mellitus

Conditions:   Genetic Variation;   Diabetes
Intervention:  
Sponsor:   National Human Genome Research Institute (NHGRI)
Completed

Genetics of Obesity, Diabetes, and Heart Disease in African Diaspora Populations

Conditions:   Diabetes;   Cardiovascular Disease
Intervention:  
Sponsor:   National Human Genome Research Institute (NHGRI)
Enrolling by invitation

MiDeTe - microRNA Levels Under Denosumab and Teriparatide Therapy in Postmenopausal Osteoporosis

Conditions:   Postmenopausal Osteoporosis;   Diabetes Type 2
Interventions:   Drug: Prolia, 60 Mg/mL Subcutaneous Solution;   Drug: Teriparatide
Sponsors:   Medical University of Vienna;   St. Vincent Hospital, Vienna
Active, not recruiting

Oral Anti Diabetic Agents in the Hospital

Condition:   Diabetes Mellitus
Interventions:   Drug: Oral Anti-diabetes Drugs alone;   Drug: Basal bolus insulin;   Drug: Supplemental insulin;   Device: (Optional) FreeStyle Libre Pro Flash Glucose Monitoring System
Sponsors:   Emory University;   National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Recruiting

Comparative Effectiveness of Family DSMES and Standard DSMES Among Diverse Populations

Condition:   Diabetes Mellitus, Type 2
Interventions:   Behavioral: Family Diabetes Self-Management Education and Support;   Behavioral: Standard Diabetes Self-Management Education and Support
Sponsors:   University of Arkansas;   Patient-Centered Outcomes Research Institute
Not yet recruiting

Metabolic Syndrome in Diabetic Smokers Using Cigarettes & Combustion-Free Nicotine Delivery Systems

Conditions:   Cardiovascular Risk Factor;   Diabetes Mellitus, Type 2
Interventions:   Other: TOBACCO CIGARETTES;   Other: COMBUSTION-FREE NICOTINE DELIVERY SYSTEMS (C-F NDS)
Sponsors:   Eclat Srl.;   University of Catania
Not yet recruiting

A Research Study Comparing Active Drug in the Blood in Healthy Participants Following Dosing of the Current and a New Formulation (C) Semaglutide Tablets

Conditions:   Healthy Volunteers;   Type 2 Diabetes
Intervention:   Drug: Oral semaglutide
Sponsor:   Novo Nordisk A/S
Active, not recruiting

A Research Study Comparing Active Drug in the Blood in Healthy Participants Following Dosing of the Current and a New Formulation (D) Semaglutide Tablets

Conditions:   Healthy Volunteers;   Type 2 Diabetes
Intervention:   Drug: Oral semaglutide
Sponsor:   Novo Nordisk A/S
Active, not recruiting

Impact of Acetaminophen on Performance of Guardian™ Sensor (3) in Adults

Conditions:   Type 1 Diabetes Mellitus;   Type 2 Diabetes Mellitus
Intervention:   Device: One time acetaminophen ingestion while wearing Guardian™ Sensor (3) connected to a Guardian™ Connect Transmitter
Sponsor:   Medtronic Diabetes
Recruiting

Performance Evaluation of an Advanced Algorithm With CGM in Adults, Adolescents, and Pediatrics

Conditions:   Type 1 Diabetes Mellitus;   Type2 Diabetes Mellitus
Intervention:   Device: Guardian™ Sensor (3) connected to a Guardian™ Connect Transmitter
Sponsor:   Medtronic Diabetes
Active, not recruiting

Reversibility of Brain Glucose Transport and Metabolism in T2DM: an Intervention Study

Condition:   Diabete Type 2
Intervention:   Behavioral: Intensification of insulin regimen/Nutrition
Sponsor:   Yale University
Not yet recruiting

Famine From Feast: Linking Vitamin C, Red Blood Cell Fragility, and Diabetes

Condition:   Diabetes Type 2
Intervention:   Dietary Supplement: Vitamin C
Sponsor:   National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Recruiting

Natural History of Autoimmune Diabetes and Its Complications

Conditions:   Diabetes Mellitus Type 1;   Diabetes Mellitus Type 2
Intervention:  
Sponsor:   National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Recruiting

The Predictive Value of Sidestream Dark Field Imaging in Diabetic Nephropathy

Condition:   Microcirculation Detection in Diabetic Patients
Intervention:   Device: Sidestream dark field(SDF) imagining
Sponsor:   Third Military Medical University
Recruiting

Hypertriglyceridaemia - Cause and Effects

Condition:   Hypertriglyceridaemia
Intervention:  
Sponsor:   Manchester University NHS Foundation Trust
Recruiting

Fat Cell Size in Insulin Resistance

Condition:   Obesity
Intervention:  
Sponsor:   National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Completed

Non-exercise Physical Activity Intervention

Conditions:   Diabete Mellitus;   Aging;   Cognitive Change
Interventions:   Behavioral: Sitting;   Behavioral: Static standing;   Behavioral: Dynamic standing
Sponsors:   Science and Research Centre Koper;   University of Michigan
Recruiting

Effect of Reflexology on Diabetic Foot and Glycemic Control in Elderly Diabetic Individuals

Conditions:   Reflexology;   Type 2 Diabetes;   Older People
Intervention:   Other: Foot reflexology
Sponsors:   Abant Izzet Baysal University;   The Scientific and Technological Research Council of Turkey
Completed

Research Study of How Well Semaglutide Works in People Living With Overweight or Obesity

Conditions:   Overweight;   Obesity;   Diabetes Mellitus, Type 2
Interventions:   Drug: Semaglutide;   Drug: Placebo (semaglutide)
Sponsor:   Novo Nordisk A/S
Not yet recruiting

Can Teaching People to be Self-compassionate Increase Physical Activity in People Who Are Pre-diabetic?

Condition:   PreDiabetes
Interventions:   Behavioral: Self-compassion;   Behavioral: Control Group
Sponsors:   University of Manitoba;   Canadian Institutes of Health Research (CIHR)
Not yet recruiting

Carbohydrate Loading and Diabetes in Colorectal Surgery

Conditions:   Diabetes Mellitus, Type 2;   Surgery;   Surgery--Complications
Intervention:   Dietary Supplement: Pre-operative carbohydrate drink
Sponsor:   University of Alberta
Active, not recruiting

Molecular and Clinical Profile of Diabetes Mellitus and Its Complications

Conditions:   Diabetes Mellitus, Type 2;   Diabetic Nephropathy;   Obesity
Intervention:  
Sponsor:   National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Suspended

L-arginine and Asymmetric Dimethylarginine (ADMA) and Lifestyle Protocols

Conditions:   Diabetes Mellitus, Type 2;   Obesity;   Arginine;   Asymmetric Dimethylarginine
Intervention:   Behavioral: Acute dietary protocols and lifestyle modification
Sponsors:   Tel-Aviv Sourasky Medical Center;   Wolfson Medical Center
Completed

A Multiple Dose Study Of Ertugliflozin (PF-04971729, MK-8835) In Otherwise Healthy Overweight And Obese Volunteers (MK-8835-037)

Condition:   Healthy Volunteer
Interventions:   Drug: Ertugliflozin;   Drug: Placebo to Ertugliflozin
Sponsors:   Merck Sharp & Dohme Corp.;   Pfizer
Completed

COVID-19 in the Swedish ICU-cohort: Risk Factors of Critical Care Admission and Intensive Care Mortality

Conditions:   COVID-19;   Critical Illness
Intervention:   Other: COVID-19 and Intensive Care
Sponsors:   Uppsala University;   Center for Clinical Research Dalarna, Sweden
Not yet recruiting

Low-Carbohydrate Dietary Pattern on Glycemic Outcomes Trial

Conditions:   Diabetes;   PreDiabetes;   Metabolic Disease;   Hyperglycemia;   Diet Modification;   Glucose Intolerance;   Glucose Metabolism Disorders (Including Diabetes Mellitus);   Endocrine System Diseases
Intervention:   Behavioral: Low-Carbohydrate Diet
Sponsors:   Tulane University School of Public Health and Tropical Medicine;   National Institute of General Medical Sciences (NIGMS)
Recruiting

The Effect of Dapagliflozin on Platelet Function testinG Profiles in Diabetic PatiEnts.

Condition:   Platelet Dysfunction
Intervention:   Drug: DAPA Tx
Sponsor:   The University of The West Indies
Recruiting

Lipid Profile and Diabetes Mellitus in People With HIV

Conditions:   HIV Infections;   Dyslipidemias;   Diabetes Mellitus;   Cardiovascular Risk Factor
Intervention:  
Sponsors:   Igor Grabovac;   Merck Gesellschaft mbH, Austria
Not yet recruiting

Web-based Weight Loss Intervention

Condition:   Overweight and Obesity
Interventions:   Behavioral: Lower carbohydrate diet;   Behavioral: Higher fiber diet;   Behavioral: Physical activity focused
Sponsor:   23andMe, Inc.
Completed

Vitamin E Pharmacokinetics and Biomarkers in Normal and Obese Women

Conditions:   Diabetes;   Fatty Liver;   Obesity;   Healthy Volunteers
Interventions:   Drug: Alpha Tocopherol Vitamin E;   Other: Vitamin C
Sponsor:   National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Recruiting

SGLT2 Inhibition in Older Obese Adults With Pre-diabetes

Condition:   Aging
Interventions:   Drug: Dapagliflozin 10 mg;   Behavioral: Nutritional counseling
Sponsor:   The University of Texas Health Science Center at San Antonio
Not yet recruiting

The Effect of Buckwheat and Couscous on Satiety and Food Intake in Young Adults

Conditions:   Food;   Eating;   Appetite
Interventions:   Other: Food-1;   Other: Food-2;   Other: Food-3
Sponsor:   Mount Saint Vincent University
Active, not recruiting

Association Between Food/Nutrient Intake and Sleep Quality in Middle Aged and Older Population

Condition:   Sleep
Intervention:  
Sponsor:   National University, Singapore
Completed

High-intensity Interval Training for Cardiometabolic Health in Persons With Spinal Cord Injury

Condition:   Paraplegia
Intervention:   Behavioral: High-intensity interval training
Sponsor:   University of Bath
Not yet recruiting

Effect of Gut Microbiome Restoration on Primary Hypertension Via Dietary Intervention

Condition:   Hypertension
Interventions:   Dietary Supplement: Innovative Dietary Formulation (Patent ID: CN110250417A);   Drug: Losartan 50mg per day
Sponsors:   Chinese Academy of Medical Sciences, Fuwai Hospital;   National Natural Science Foundation of China
Not yet recruiting

Study of the Reversibility of Glucose Intolerance Caused by Chronic Aspartame Consumption

Condition:   Glucose Metabolism Disorder
Interventions:   Other: Oral glucose tolerance test (OGTT);   Other: Diet soda containing aspartame only
Sponsor:   Rockefeller University
Completed

Altered Tumor Oxygenation by Metformin, a Potential Step in Overcoming Radiotherapy Resistance in LACC

Condition:   Cervical Cancer
Interventions:   Drug: Metformin;   Drug: Cisplatin
Sponsor:   Oslo University Hospital
Recruiting

DIgital Assisted MONitoring for DiabeteS - I

Condition:   Diabetes Mellitus
Interventions:   Procedure: Use of software-implemented glucometer for real-time collection and transmission of measured glucose values to remote server.;   Procedure: Use of regular glucometer
Sponsors:   University of Bari;   Eli Lilly and Company;   LifeScan
Completed

Non-insulino-dependant Diabetes in Infants and Teenagers

Conditions:   Diabetes;   Pediatric Disorder
Intervention:  
Sponsor:   Centre Hospitalier Universitaire de la Réunion
Recruiting

New Onset Type 1 Diabetes: Role of Exenatide

Condition:   Type 1 Diabetes
Interventions:   Drug: Exenatide;   Drug: Rapid and long acting insulin;   Drug: long acting insulin + rapid acting + 1.25 mcg Exenatide
Sponsors:   Albert Einstein College of Medicine;   National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Completed

Redox Imbalance and the Development of Cystic Fibrosis Diabetes

Conditions:   Diabetes Mellitus, Type 2;   Cystic Fibrosis
Interventions:   Other: Oral Glucose Tolerance Test;   Other: High Glycemic Index Meal;   Other: Low Glycemic Index Meal;   Other: Test Soda;   Other: Fruit juice
Sponsors:   Emory University;   Cystic Fibrosis Foundation
Completed

A Natural History of Perioperative Metabolism

Conditions:   Surgery;   Anesthesia;   Insulin Sensitivity;   Metabolic Stress Hyperglycemia
Intervention:  
Sponsor:   University of Vermont Medical Center
Completed

Safety of Bosentan in Type II Diabetic Patients

Condition:   Diabetes Mellitus
Interventions:   Drug: Bosentan;   Drug: Placebo
Sponsors:   Retinset SL;   Instituto Universitario de Oftalmobiología Aplicada (Institute of Applied Ophthalmobiology) - IOBA
Suspended

Audit and Feedback for General Practitioners in the Intego Network

Conditions:   Diabetes Mellitus;   Chronic Kidney Diseases;   Heart Failure
Intervention:   Other: Extended audit and feedback in GPs electronic health record
Sponsor:   Tine De Burghraeve
Not yet recruiting

Healthy Living Partnerships for Veterans With Migraine

Conditions:   Migraine;   Migraine Disorders;   Migraine With Aura;   Migraine Without Aura
Intervention:   Behavioral: Intensive Lifestyle Intervention
Sponsors:   Wake Forest University Health Sciences;   W.G. "Bill" Hefner Salisbury VA Medical Center
Not yet recruiting

Prevention of Chemotherapy-Related Polyneuropathy Via Sensorimotor Exercise Training

Conditions:   Exercise;   Chemotherapy-induced Polyneuropathy
Intervention:   Behavioral: Exercise
Sponsors:   German Cancer Research Center;   University Hospital Heidelberg;   National Center for Tumor Diseases, Heidelberg
Completed

mulTi-Arm Therapeutic Study in Pre-ICu Patients Admitted With Covid-19 - Experimental Drugs and Mechanisms

Condition:   COVID-19
Interventions:   Drug: EDP1815;   Drug: Dapagliflozin;   Drug: Ambrisentan;   Other: Standard of care
Sponsor:   Cambridge University Hospitals NHS Foundation Trust
Not yet recruiting

Pancreatic Islet Transplantation Into the Anterior Chamber of the Eye

Condition:   Diabetes
Intervention:   Biological: Human Pancreatic Islet Transplantation
Sponsors:   Midhat H. Abdulreda;   Diabetes Research Institute Foundation;   Bascom Palmer Eye Institute
Recruiting

A 5-year Longitudinal Observational Study of Patients With Nonalcoholic Fatty Liver (NAFL) or Nonalcoholic Steatohepatitis (NASH)

Conditions:   Nonalcoholic Fatty Liver;   Nonalcoholic Steatohepatitis
Intervention:  
Sponsor:   Target PharmaSolutions, Inc.
Recruiting

Cardio-Cerebrovascular Co-Prevention and Co-Management Based on Internet+

Conditions:   Cardiovascular Diseases;   Myocardial Ischemia;   Cerebrovascular Disorders;   Stroke;   Internet-Based Intervention
Interventions:   Behavioral: Establishment of individual health records;   Behavioral: Cardiovascular risk assessment;   Behavioral: Popularization of medical knowledge;   Behavioral: Personalized Reminders;   Drug: Routine treatment
Sponsors:   Nanfang Hospital of Southern Medical University;   Nanhai Hospital, Southern Medical University
Not yet recruiting

E-health Intervention for Cardiac Rehabilitation

Conditions:   Coronary Heart Disease;   Valve Disease, Heart
Interventions:   Behavioral: Virtual Cardiac Rehabilitation Program;   Behavioral: Case Managed Home Program
Sponsor:   Ottawa Heart Institute Research Corporation
Recruiting

Vestibular Stimulation to Trigger Adipose Loss (VeSTAL) Clinical Trial

Condition:   Obesity
Intervention:   Device: VeSTAL
Sponsors:   Neurovalens Ltd.;   University of California, San Diego;   University of Ulster;   Exploristics;   Compliance Solutions
Recruiting